Ubiquitin at the crossroad of cell death and survival.

Yu-Shan Chen, Xiao-Bo Qiu
Author Information
  1. Yu-Shan Chen: Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, and College of Life Sciences, Beijing Normal University, Beijing 100875, P. R. China. xqiu@bnu.edu.cn.

Abstract

Ubiquitination is crucial for cellular processes, such as protein degradation, apoptosis, autophagy, and cell cycle progression. Dysregulation of the ubiquitination network accounts for the development of numerous diseases, including cancer. Thus, targeting ubiquitination is a promising strategy in cancer therapy. Both apoptosis and autophagy are involved in tumorigenesis and response to cancer therapy. Although both are categorized as types of cell death, autophagy is generally considered to have protective functions, including protecting cells from apoptosis under certain cellular stress conditions. This review highlights recent advances in understanding the regulation of apoptosis and autophagy by ubiquitination.

References

  1. Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2885-90 [PMID: 10077606]
  2. Curr Cancer Drug Targets. 2005 Feb;5(1):3-8 [PMID: 15720184]
  3. J Hepatol. 2010 May;52(5):698-704 [PMID: 20347499]
  4. Nature. 2012 Jan 5;481(7379):90-3 [PMID: 22113614]
  5. Nature. 2000 Oct 12;407(6805):802-9 [PMID: 11048732]
  6. Cell Cycle. 2009 May 15;8(10):1571-6 [PMID: 19377293]
  7. Apoptosis. 2012 Nov;17(11):1210-22 [PMID: 22923157]
  8. Cell. 2000 Oct 13;103(2):351-61 [PMID: 11057907]
  9. Cancer Res. 2011 Mar 1;71(5):2010-20 [PMID: 21212414]
  10. J Virol. 2005 Jul;79(14):9296-300 [PMID: 15994823]
  11. Cancer Res. 2010 Jun 1;70(11):4728-38 [PMID: 20484041]
  12. Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8662-7 [PMID: 11447297]
  13. Cancer Cell. 2002 Apr;1(3):237-46 [PMID: 12086860]
  14. Nat Rev Cancer. 2002 Jun;2(6):420-30 [PMID: 12189384]
  15. Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):3850-5 [PMID: 10725400]
  16. Cell. 1997 Aug 8;90(3):405-13 [PMID: 9267021]
  17. Int J Cancer. 2010 Sep 1;127(5):1072-80 [PMID: 20039318]
  18. J Biol Chem. 2011 Oct 14;286(41):35380-35387 [PMID: 21849505]
  19. Sci Signal. 2010 May 25;3(123):ra42 [PMID: 20501938]
  20. Cancer Cell. 2011 Aug 16;20(2):214-28 [PMID: 21840486]
  21. Nat Cell Biol. 2004 Sep;6(9):849-60 [PMID: 15300255]
  22. Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18511-6 [PMID: 20937856]
  23. Genes Dev. 1999 Feb 1;13(3):270-83 [PMID: 9990852]
  24. Mol Cell. 2008 Jun 20;30(6):678-88 [PMID: 18570871]
  25. J Biol Chem. 2005 Jan 7;280(1):174-82 [PMID: 15507451]
  26. Nat Rev Cancer. 2006 Oct;6(10):776-88 [PMID: 16990855]
  27. Trends Cell Biol. 2004 Mar;14(3):103-6 [PMID: 15055197]
  28. N Engl J Med. 2003 Jun 26;348(26):2609-17 [PMID: 12826635]
  29. EMBO J. 2012 Feb 1;31(3):576-92 [PMID: 22124327]
  30. Int J Cancer. 2006 Aug 1;119(3):718-21 [PMID: 16496380]
  31. Curr Drug Targets Inflamm Allergy. 2002 Jun;1(2):137-49 [PMID: 14561196]
  32. Cell Mol Biol Lett. 2008;13(3):353-65 [PMID: 18311545]
  33. Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):E119-26 [PMID: 22233804]
  34. EMBO Rep. 2009 Jul;10(7):706-13 [PMID: 19543231]
  35. Nature. 2010 Jan 7;463(7277):103-7 [PMID: 20023629]
  36. Nat Struct Mol Biol. 2011 Nov 06;18(12):1336-44 [PMID: 22056774]
  37. J Cell Biol. 2012 Apr 30;197(3):361-7 [PMID: 22529100]
  38. Autophagy. 2008 Oct;4(7):949-51 [PMID: 18769111]
  39. Cancer Res. 2010 Jul 15;70(14):5994-6003 [PMID: 20587519]
  40. Nature. 2011 Jun 2;474(7349):105-8 [PMID: 21532592]
  41. Cell. 2000 Jul 7;102(1):33-42 [PMID: 10929711]
  42. J Pathol. 2006 Apr;208(5):724-32 [PMID: 16450335]
  43. FEBS J. 2012 Feb;279(3):370-83 [PMID: 22103682]
  44. Biochemistry. 2011 Dec 27;50(51):11084-96 [PMID: 22103349]
  45. Clin Cancer Res. 2000 May;6(5):1796-803 [PMID: 10815900]
  46. J Biol Chem. 2003 Feb 7;278(6):4028-34 [PMID: 12446669]
  47. Genes Dev. 2007 Nov 15;21(22):2861-73 [PMID: 18006683]
  48. Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4870-5 [PMID: 21383157]
  49. J Clin Invest. 2006 Jan;116(1):174-81 [PMID: 16395405]
  50. Mol Cell. 2012 Oct 26;48(2):242-53 [PMID: 22959274]
  51. Nature. 2009 Apr 9;458(7239):732-6 [PMID: 19360080]
  52. J Cell Biol. 2007 May 21;177(4):613-24 [PMID: 17502423]
  53. Nat Genet. 2003 Oct;35(2):165-70 [PMID: 12973351]
  54. Cancer Cell. 2004 May;5(5):417-21 [PMID: 15144949]
  55. Cell Death Differ. 2013 Feb;20(2):281-92 [PMID: 22976837]
  56. Mol Cell Biol. 2012 Jan;32(2):320-32 [PMID: 22037769]
  57. J Biol Chem. 2010 May 28;285(22):16614-22 [PMID: 20360002]
  58. J Cell Sci. 2011 Aug 1;124(Pt 15):2631-41 [PMID: 21750192]
  59. Nat Struct Mol Biol. 2007 Feb;14(2):167-8 [PMID: 17206147]
  60. Oncogene. 2005 Jan 6;24(1):1-10 [PMID: 15637585]
  61. Nat Rev Drug Discov. 2006 Jul;5(7):596-613 [PMID: 16816840]
  62. Cancer Invest. 2004;22(2):304-11 [PMID: 15199612]
  63. PLoS One. 2012;7(8):e44254 [PMID: 22952942]
  64. Leuk Lymphoma. 2003 Nov;44(11):1935-41 [PMID: 14738146]
  65. Carcinogenesis. 2010 Mar;31(3):402-10 [PMID: 20015862]
  66. Nat Genet. 2004 Jun;36(6):585-95 [PMID: 15146184]
  67. Cell. 2011 Sep 30;147(1):223-34 [PMID: 21962518]
  68. Blood. 2010 May 6;115(18):3796-800 [PMID: 20203261]
  69. Cold Spring Harb Perspect Biol. 2010 Mar;2(3):a003350 [PMID: 20300215]
  70. J Exp Med. 1999 Jun 7;189(11):1815-22 [PMID: 10359585]
  71. Nat Cell Biol. 2002 Jun;4(6):445-50 [PMID: 12021771]
  72. EMBO J. 2004 Feb 25;23(4):800-10 [PMID: 14765125]
  73. PLoS One. 2012;7(2):e32584 [PMID: 22393418]
  74. J Biol Chem. 2012 Sep 14;287(38):32236-45 [PMID: 22815481]
  75. Mol Cell. 2009 May 15;34(3):259-69 [PMID: 19450525]
  76. Nat Rev Cancer. 2012 Apr 26;12(6):401-10 [PMID: 22534666]
  77. Biochem J. 2004 Mar 15;378(Pt 3):727-34 [PMID: 14748687]
  78. Nat Immunol. 2009 Nov;10(11):1215-21 [PMID: 19820708]
  79. Nature. 2011 Mar 31;471(7340):637-41 [PMID: 21455181]
  80. Oncogene. 2010 Mar 25;29(12):1717-9 [PMID: 20101204]
  81. J Virol. 2011 Jan;85(1):51-63 [PMID: 20980512]
  82. Genes Dev. 2008 Aug 15;22(16):2256-66 [PMID: 18708583]
  83. Hum Mol Genet. 2001 May 1;10(10):1019-27 [PMID: 11331612]
  84. Nat Rev Mol Cell Biol. 2005 Jan;6(1):9-20 [PMID: 15688063]
  85. Int J Biochem Cell Biol. 2004 Dec;36(12):2405-19 [PMID: 15325581]
  86. Cell. 2006 Jul 14;126(1):121-34 [PMID: 16839881]
  87. J Natl Cancer Inst. 2006 Feb 15;98(4):285-8 [PMID: 16478747]
  88. Nat Med. 2011 Dec 11;18(1):91-9 [PMID: 22157679]

MeSH Term

Apoptosis
Autophagy
Cell Death
Cell Survival
Humans
Molecular Targeted Therapy
Neoplasms
Proteolysis
Ubiquitin
Ubiquitination

Chemicals

Ubiquitin

Word Cloud

Created with Highcharts 10.0.0apoptosisautophagycellubiquitinationcancercellularincludingtherapydeathUbiquitinationcrucialprocessesproteindegradationcycleprogressionDysregulationnetworkaccountsdevelopmentnumerousdiseasesThustargetingpromisingstrategyinvolvedtumorigenesisresponseAlthoughcategorizedtypesgenerallyconsideredprotectivefunctionsprotectingcellscertainstressconditionsreviewhighlightsrecentadvancesunderstandingregulationUbiquitincrossroadsurvival

Similar Articles

Cited By